Braunschweiger P - Search Results

1

The CITI program: an international online resource for education in human subjects protection and the responsible conduct of research.

Braunschweiger P, Goodman KW. Braunschweiger P, et al. Acad Med. 2007 Sep;82(9):861-4. doi: 10.1097/ACM.0b013e31812f7770. Acad Med. 2007. PMID: 17726392

2

Consensus standards for introductory e-learning courses in human participants research ethics.

Williams JR, Sprumont D, Hirtle M, Adebamowo C, Braunschweiger P, Bull S, Burri C, Czarkowski M, Fan CT, Franck C, Gefenas E, Geissbuhler A, Klingmann I, Kouyaté B, Kraehenbhul JP, Kruger M, Moodley K, Ntoumi F, Nyirenda T, Pym A, Silverman H, Tenorio S. Williams JR, et al. Among authors: braunschweiger p. J Med Ethics. 2014 Jun;40(6):426-8. doi: 10.1136/medethics-2013-101572. Epub 2013 Aug 19. J Med Ethics. 2014. PMID: 23959838 Free PMC article.

3

Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types.

Subbarayan PR, Wang PG, Lampidis TJ, Ardalan B, Braunschweiger P. Subbarayan PR, et al. Among authors: braunschweiger p. J Chemother. 2008 Feb;20(1):106-11. doi: 10.1179/joc.2008.20.1.106. J Chemother. 2008. PMID: 18343752

4

Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols.

Hou Y, Wang J, Andreana PR, Cantauria G, Tarasia S, Sharp L, Braunschweiger PG, Wang PG. Hou Y, et al. Among authors: braunschweiger pg. Bioorg Med Chem Lett. 1999 Aug 2;9(15):2255-8. doi: 10.1016/s0960-894x(99)00363-7. Bioorg Med Chem Lett. 1999. PMID: 10465556

5

Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.

Cantuaria G, Magalhaes A, Penalver M, Angioli R, Braunschweiger P, Gomez-Marin O, Kanhoush R, Gomez-Fernandez C, Nadji M. Cantuaria G, et al. Among authors: braunschweiger p. Gynecol Oncol. 2000 Oct;79(1):33-7. doi: 10.1006/gyno.2000.5910. Gynecol Oncol. 2000. PMID: 11006027

6

Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.

Braunschweiger PG, Basrur VS, Santos O, Markoe AM, Houdek PV, Schwade JG. Braunschweiger PG, et al. Cancer Res. 1993 Mar 1;53(5):1091-7. Cancer Res. 1993. PMID: 8439953

7

Expression of glucose transporter-1 in cervical cancer and its precursors.

Mendez LE, Manci N, Cantuaria G, Gomez-Marin O, Penalver M, Braunschweiger P, Nadji M. Mendez LE, et al. Among authors: braunschweiger p. Gynecol Oncol. 2002 Aug;86(2):138-43. doi: 10.1006/gyno.2002.6745. Gynecol Oncol. 2002. PMID: 12144819

8

Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.

Braunschweiger PG, Jones SA, Johnson CS, Furmanski P. Braunschweiger PG, et al. Cancer Res. 1991 Oct 15;51(20):5454-60. Cancer Res. 1991. PMID: 1913664

9

Radioresistance in murine solid tumors induced by interleukin-1.

Braunschweiger PG, Basrur V, Santos O, Adessa A, Houdek P, Markoe AM. Braunschweiger PG, et al. Radiat Res. 1996 Feb;145(2):150-6. Radiat Res. 1996. PMID: 8606924

10

In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors.

Braunschweiger PG, Poulakos L, Schiffer LM. Braunschweiger PG, et al. Cancer Res. 1976 May;36(5):1748-53. Cancer Res. 1976. PMID: 1268832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results